Alvotech ALVO
NASDAQ ALVO
$4.43 +0.16 (+3.75%)
At close: Aug 21, 2026 · 4:00 PM EDT

Alvotech (ALVO) Preferred Stock Liabilities (2021)

Alvotech's (ALVO) quarterly Preferred Stock Liabilities came in at $250.0 million in Q4 2021.

Alvotech (ALVO) Preferred Stock Liabilities (2021) Analysis & Trends

Alvotech (ALVO) has 1 years of Preferred Stock Liabilities data on file, last reported at $250.0 million in Q4 2021.

  • Quarterly Preferred Stock Liabilities changed N/A year-over-year to $250.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $250.0 million (changed N/A YoY) and the FY2021 annual result came in at $250.0 million, changed N/A from the prior year.
  • Preferred Stock Liabilities held at $250.0 million in Q4 2021.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $250.0 million in Q4 2021 to a low of $250.0 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Alvotech 1.30 Bn 1.30 Bn 5.09 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 250.00 Mn